Movie & TV
Past 24 hours
Past 7 days
Past 30 days
Stock Market Today With Jim Cramer: Civil Unrest on Main Street
Jim Cramer discusses the stock market today including the protests in America, Gilead Sciences Covid-19 drug disappoints, and ...
Companies, Athletes Take a Stand: Top Sports, Business News
Now, for anyone tuning into business news, the question has to be asked: Is Wall Street ignoring what’s happening on Main ...
BlackBerry Rises on Fairfax Talks to Acquire Rest of Shares
BlackBerry climbs on reports that Fairfax Financial Holdings held talks about acquiring the remaining shares of the company.
Facebook Workers Stage Walkout to Protest Policy on Trump Posts
Facebook employees reportedly staged a virtual walkout on Monday over Mark Zuckerberg's position on recent posts by Trump.
CrowdStrike Analysts Lift Share-Price Targets
Get Report shares on Monday rose after two analysts raised their share-price targets for the cybersecurity firm. Barclays ...
Speculators Dump Gold But Price Goes Up Anyway
Judging from futures and alleged jewelry demand, the price of gold ought to be falling. But it isn't. Let's explore what's ...
Goldman Sachs Sees Less of a Drop in the S&P 500
Goldman Sachs in a report sees less of a drop in the S&P 500 than it predicted three weeks ago. Goldman Sachs analysts now ...
Pfizer Stock Is Below Key Moving Averages - Where From Here?
The trade: Reduce holdings on Pfizer on strength to its 200-week simple moving average and its monthly risky level.
5 Things You Won't Believe Are Taxed
From a bonus at work to slot machine winnings, here are 5 surprising things that must be reported as income on your tax ...
HollyFrontier Refinery Conversion to Cost 200 Jobs
The switch from refinery to renewable diesel production will lead to the loss of up to 200 jobs over the next 18 months.
Will Virgin Galactic Lift Off After Successful SpaceX Launch?
Virgin Galactic rallies after a successful launch by SpaceX over the weekend. Now investors are looking to see if SPCE can ...
Abbott Downgraded to Sell by Goldman Sachs
Abbott Laboratories falls after Goldman Sachs says it thinks the 'stock currently implies a likely overreaction to current ...